Report Categories Report Categories

Report Categories

industry Category

All

Total: 3 records, 1 pages

Global Quetiapine Fumarate API Supply, Demand and Key Producers, 2024-2030

date 25 Feb 2024

date Chemical & Material

new_biaoQian Quetiapine Fumarate API

The global Quetiapine Fumarate API market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Quetiapine Fumarate API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Chemical & Material

new_biaoQian Quetiapine Fumarate API

According to our (Global Info Research) latest study, the global Quetiapine Fumarate API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Quetiapine Fumarate API Supply, Demand and Key Producers, 2023-2029

date 14 Mar 2023

date Chemical & Material

new_biaoQian Quetiapine Fumarate API

Quetiapine is an atypical antipsychotic approved for the treatment of schizophrenia, bipolar disorder, and along with an antidepressant to treat major depressive disorder.

USD4480.00

Add To Cart

Add To Cart

industry 25 Feb 2024

industry Chemical & Material

new_biaoQian Quetiapine Fumarate API

The global Quetiapine Fumarate API market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Chemical & Material

new_biaoQian Quetiapine Fumarate API

According to our (Global Info Research) latest study, the global Quetiapine Fumarate API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 14 Mar 2023

industry Chemical & Material

new_biaoQian Quetiapine Fumarate API

Quetiapine is an atypical antipsychotic approved for the treatment of schizophrenia, bipolar disorder, and along with an antidepressant to treat major depressive disorder.

USD4480.00

addToCart

Add To Cart